Quanterix Corporation
$3.3
▲
8.91%
2026-04-21 09:02:00
www.quanterix.com
NGM: QTRX
Explore Quanterix Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$164.29 M
Current Price
$3.3
52W High / Low
$8.77 / $3.23
Stock P/E
—
Book Value
$6.33
Dividend Yield
—
ROCE
-31.92%
ROE
-34.25%
Face Value
—
EPS
$-2.51
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
450
Beta
1.32
Debt / Equity
12.59
Current Ratio
2.84
Quick Ratio
2.11
Forward P/E
-1.76
Price / Sales
1.14
Enterprise Value
$76.73 M
EV / EBITDA
-1.07
EV / Revenue
0.55
Rating
None
Target Price
$7.33
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 2. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
| 3. | Inogen, Inc. | $6.95 | — | $185.18 M | — | -12.85% | -12.43% | $9.13 / $5.34 | $7.06 |
| 4. | Bio-Rad Laboratories, Inc. | NOT FOUND | — | — | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 5. | Baird Medical Investment Holdings Limited | $1.79 | 55.75 | $64.64 M | — | 35.34% | -8.03% | $7.26 / $0.76 | $1.34 |
| 6. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 7. | Viemed Healthcare, Inc. | $9.66 | 24.97 | $372.9 M | — | 13.1% | 11.11% | $10.06 / $5.93 | $3.72 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 43.78 M | 40.15 M | 24.45 M | 30.27 M | 34.11 M | — |
| Operating Profit | -23.87 M | -30.15 M | -29.43 M | -26.37 M | -14.77 M | — |
| Net Profit | -23.12 M | -33.52 M | -30.01 M | -20.5 M | -11.63 M | — |
| EPS in Rs | -0.49 | -0.71 | -0.64 | -0.44 | -0.25 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 138.65 M | 135.44 M | 121.14 M | 104.95 M |
| Operating Profit | -109.81 M | -52.62 M | -44.66 M | -74.71 M |
| Net Profit | -107.15 M | -38.53 M | -28.35 M | -99.57 M |
| EPS in Rs | -2.28 | -0.82 | -0.6 | -2.12 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 418.77 M | 406.53 M | 428.57 M | 433.58 M |
| Total Liabilities | 123.04 M | 76.5 M | 78.61 M | 75.65 M |
| Equity | 295.73 M | 330.04 M | 349.96 M | 357.93 M |
| Current Assets | 212.26 M | 363.59 M | 382.1 M | 381.52 M |
| Current Liabilities | 74.76 M | 42.01 M | 38.98 M | 31.35 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -77.24 M | -35.16 M | -18.85 M | -48.61 M |
| Investing CF | 50.23 M | -82.27 M | -148.45 M | -11.09 M |
| Financing CF | -0.71 M | 0.46 M | 2.69 M | 2.31 M |
| Free CF | -79.85 M | -38.53 M | -22.69 M | -60.23 M |
| Capex | -2.61 M | -3.37 M | -3.84 M | -11.61 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11.8% | 15.42% | — | — |
| Earnings Growth % | -35.89% | 71.52% | — | — |
| Profit Margin % | -28.45% | -23.41% | -94.88% | — |
| Operating Margin % | -38.85% | -36.87% | -71.18% | — |
| Gross Margin % | 59.89% | 60.26% | 42.68% | — |
| EBITDA Margin % | -32.68% | -30.03% | -65.35% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.